# Neurobiological Basis of Response to Vyvanse in Adults With ADHD: an fMRI Study of Brain Activation

> **NCT01924429** · PHASE4 · COMPLETED · sponsor: **Jeffrey Newcorn** · enrollment: 30 (actual)

## Conditions studied

- ADHD

## Interventions

- **DRUG:** Lisdexamfetamine

## Key facts

- **NCT ID:** NCT01924429
- **Lead sponsor:** Jeffrey Newcorn
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01924429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01924429, "Neurobiological Basis of Response to Vyvanse in Adults With ADHD: an fMRI Study of Brain Activation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01924429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*